Cargando…
Hemagglutinating virus of Japan‐envelope containing programmed cell death‐ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma
The programmed cell death‐1/programmed cell death‐ligand 1 (PD‐1/PD‐L1) pathway is involved in preventing immune system‐mediated destruction of malignant tumors including glioblastoma. However, the therapeutic influence of PD‐1/PD‐L1 inhibition alone in glioblastoma is limited. To develop effective...
Autores principales: | Sugii, Narushi, Matsuda, Masahide, Okumura, Genki, Shibuya, Akira, Ishikawa, Eiichi, Kaneda, Yasufumi, Matsumura, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780057/ https://www.ncbi.nlm.nih.gov/pubmed/33155337 http://dx.doi.org/10.1111/cas.14721 |
Ejemplares similares
-
IM-6 HVJ-E containing PD-L1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma
por: Sugii, Narushi, et al.
Publicado: (2021) -
Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment
por: Miyazaki, Tsubasa, et al.
Publicado: (2020) -
RT-02 POTENTIAL OF PROTON BEAM THERAPY FOR THE TREATMENT OF GLIOBLASTOMA
por: Matsuda, Masahide, et al.
Publicado: (2019) -
Delayed Brain Edema and Swelling following Craniectomy for Evacuation of an Epidural Abscess that Improved by Cranioplasty: Case Report
por: Sugii, Narushi, et al.
Publicado: (2017) -
RT-4 Treatment outcome of proton beam therapy for glioblastoma
por: Matsuda, Masahide, et al.
Publicado: (2021)